Results 91 to 100 of about 2,913 (168)

Monosodium Glutamate Supplementation Improves Bone Status in Mice Under Moderate Protein Restriction

JBMR Plus, 2019
Adequate protein intake during development is critical to ensure optimal bone gain and to attain a higher peak bone mass later. Using a mild protein restriction model in Balb/C mice consuming 6% of their total energy intake as soy protein (LP‐SOY)—for ...
Anne Blais, Gael Y Rochefort, Manon Moreau, Juliane Calvez, Xin Wu, Hideki Matsumoto, François Blachier   +6 more
doaj   +1 more source

Pyrazinamide resistance in Swedish multidrug-resistant tuberculosis 2003–2013

International Journal of Mycobacteriology, 2015
Aims and objectives: The aim of this study is to determine the prevalence of pyrazinamide (PZA) resistance among multidrug-resistant Mycobacterium tuberculosis (MDR-TB) strains isolated in Sweden between 2003 and 2013 and to study the correlation between
M Mansjö, J Werngren, S Hoffner
doaj  

Estandarización de una técnica de complementación del gen pncA en Mycobacterium tuberculosis pncA-knockout: herramienta para el estudio de la relación entre mutaciones en pncA y parámetros fenotípicos

, 2019
Mutaciones en el gen pncA son la mayor causa de resistencia a pirazinamida (PZA), pero existen mecanismos alternativos que también aportan resistencia. El objetivo del estudio fue estandarizar la técnica de complementación del gen pncA en Mycobacterium tuberculosis H37Rv pncA-KO para evaluar el efecto de las mutaciones en el gen pncA sobre parámetros ...
openaire   +1 more source

Pyrazinamide susceptibility testing in <i>Mycobacterium tuberculosis</i>: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate diagnosis in a low-MDR-TB-incidence context. [PDF]

Front Cell Infect Microbiol
Semenova T, Gonzalez G, Lechartier B, Sander P, von Garnier C, Schulthess B, Mazza-Stalder J, Greub G, Opota O.   +8 more
europepmc   +1 more source

Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant <i>Mycobacterium tuberculosis</i>. [PDF]

Pathogens
Gul M, Ali S, Rehman A, Qasim M, Ali R, Phelan JE, Waheed A, Ahmad S, Hussain M, Campino S, Clark TG, Khan TA.   +11 more
europepmc   +1 more source

Systematic identification of bacterial factors driving Staphylococcus aureus intracellular lifestyle in non-professional phagocytes. [PDF]

Nat Commun
Rodrigues Lopes I, Alcantara LM, Lopez-Bravo M, Liu Y, Larrouy-Maumus G, Lopez D, Mano M, Eulalio A.   +7 more
europepmc   +1 more source

Whole-Genome and Targeted Sequencing of 75 Drug-Resistant <i>Mycobacterium tuberculosis</i> Clinical Isolates in South Korea. [PDF]

Ann Lab Med
Kang YR, Son ES, Han K, Cho M, Choi S, Kim YJ, Lee JY, Kim J, Kang SJ, Lee JS, Lee HJ.   +10 more
europepmc   +1 more source

Association between overexpression of efflux pumps genes Rv0191 and Rv3008 and pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis: a multi-center study. [PDF]

BMC Infect Dis
Hashemzadeh M, Hamid S, Khosravi AD, Soleimanpour S, Savari M.   +4 more
europepmc   +1 more source

Targeting <i>Mycobacterium tuberculosis</i>: The Role of Alkyl Substitution in Pyrazinamide Derivatives. [PDF]

ACS Omega
Juhás M, Bouz G, Pang L, Weeks SD, Jand́ourek O, Konečná K, Paterová P, Bárta P, Halířová M, Kučerová-Chlupáčová M, Doležal M, Zitko J.   +11 more
europepmc   +1 more source

Editorial: Insights in aging, metabolism and redox biology: 2024. [PDF]

Front Aging
Dagda RK, Zhang J.
europepmc   +1 more source